Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors
- PMID: 40107274
- DOI: 10.1016/j.immuni.2025.02.022
Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors
Abstract
Central nervous system (CNS) malignancies include primary tumors, such as gliomas, and brain metastases (BrMs) originating from diverse extracranial cancers. The blood-brain barrier (BBB) is a key structural component of both primary and metastatic brain cancers. Here, we comprehensively analyzed the two major BBB cell types, endothelial and mural cells, across non-tumor brain tissue, isocitrate dehydrogenase (IDH) mutant (IDH mut) low-grade gliomas, IDH wild-type (IDH WT) high-grade glioblastomas (GBMs), and BrMs from various primary tumors. Bulk and single-cell RNA sequencing, integrated with spatial analyses, revealed that GBMs, but not low-grade gliomas, exhibit significant alterations in the tumor vasculature, including the emergence of diverse pathological vascular cell subtypes. However, these alterations are less pronounced in GBMs than in BrMs. Notably, the BrM vasculature shows higher permeability and more extensive interactions with distinct immune cell populations. This vascular atlas presents a resource toward understanding of tumor-specific vascular features in the brain, providing a foundation for developing vascular- and immune-targeting therapies.
Keywords: IDH WT glioblastoma; IDH mut glioma; RNA sequencing; brain metastasis; endothelial cells; mural cells; vasculature.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.F.H. has served on advisory boards and speaker’s bureau for Novocure and Bayer; M.E.H. has an advisory role at TME Pharma; J.A.J. received honoraria for speaking at a research symposium organized by Bristol Meyers Squibb, serving on an advisory board for T-Knife Therapeutics, and previously served on the scientific advisory board of Pionyr Immunotherapeutics (last 3 years disclosures).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical